Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Ultrasound contrast agent
Patent
1998-04-15
2000-06-27
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Ultrasound contrast agent
600458, A61K 4904
Patent
active
06080386&
ABSTRACT:
An ultrasonic imaging technique is disclosed which uses microbubbles as echo contrast agents. In general the method employs maitenance of an ultrasound signal while the contrast agent is intravenously injected into a mammal. Once all the contrast agent has been injected and transmission of the signal is suspended for a period of time sufficient for the microbubbles perfuse the organ of interest. Transmission of the ultrasound signal is then resumed and peak contrast images are obtained which rival more complicated imaging procedures such as nuclear resonance imaging.
REFERENCES:
patent: 4572203 (1986-02-01), Feinstein
patent: 4957656 (1990-09-01), Cerny et al.
patent: 5040537 (1991-08-01), Katakura
patent: 5255683 (1993-10-01), Monaghan
patent: 5380519 (1995-01-01), Schneider et al.
patent: 5410516 (1995-04-01), Uhlendorf et al.
patent: 5413774 (1995-05-01), Schneider et al.
patent: 5542935 (1996-08-01), Unger et al.
patent: 5567415 (1996-10-01), Porter
Putterman, "Sonoluminescence: Sound into Light", Scientific American, Feb. 1995, pp. 47-51.
Dees Jos,e G.
Hartley Michael G.
The Board of Regents of the University of Nebraska
LandOfFree
Suspended ultra-sound induced microbubble cavitation imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suspended ultra-sound induced microbubble cavitation imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suspended ultra-sound induced microbubble cavitation imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1781775